Update on SACHDNC Administrative Processes Sara Copeland, MD Chief, Genetics Services Branch Designated Federal Officer Secretary’s Advisory Committee.

Slides:



Advertisements
Similar presentations
Health Resources and Services Administration Maternal and Child Health Bureau Health Resources and Services Administration Maternal and Child Health Bureau.
Advertisements

Health Resources and Services Administration Maternal and Child Health Bureau Health Resources and Services Administration Maternal and Child Health Bureau.
Back to the Drawing Board Summary of the work of the Human Services Redesign Committee from May 2012 forward.
Newborn Screening & Medical Foods Policy Overview Fatty Oxidation Disorders/Organic Acidemia Association Annual Conference July 26, 2014 Melanie Lockhart.
Ad Hoc Committee Update: Impact of NCAA Sickle Cell Trait Mandate Alexis Thompson January 16, 2014.
Decision Criteria and Process Advisory Committee on Heritable Disorders in Newborns and Children February 26-27, 2009.
1 Legal Framework for the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children (SACHDNC) Legal Framework for the Secretary’s.
Newborn Screening Overview Marie Mann, M.D., M.P.H. U.S. Department of Health and Human Services Health Resources and Services Administration Maternal.
Health manpower and newborn screening Joann Bodurtha MD MPH.
Integration of Child Health Information Systems (CHIS) Public Health Data Standards Consortium March 2004 Deborah Linzer, MS MCHB/Genetic Services Branch.
Sara Copeland, MD Department of Health and Human Services
Melissa Ewerth Graduate Adapted Physical Education, WCU.
Screening for Critical Congenital Heart Disease using Pulse Oximetry Legislative Advocacy Anoop Rao PGY2, Pediatrics Image
The National Coordinating Center for the Regional Genetic and Newborn Screening Service Collaboratives (NCC/RC System) ACTions Matter: A Candid Conversation.
Recently Issued OHRP Documents: Guidance on Subject Withdrawal and Draft Revised FWA Secretary’s Advisory Committee on Human Research Protections October.
Definition of a Consumer One that consumes, especially one that acquires goods or services for direct use or ownership rather than for resale or use in.
CSHCS Strategic Planning Michigan Issues George Baker, MD I. CSHCN Definition II. System of Care.
Systematic Reviews and the American Academy of Pediatrics Virginia A. Moyer, MD, MPH Professor of Pediatrics Baylor College of Medicine.
Maternal and Child Health Bureau Partnering to Achieve Community Service Systems for CSHCN Merle McPherson, MD, MPH New Leaders Orientation.
Hospital Practices Influence Breastfeeding Rates: The Data Tell the Story Birth & Beyond California: Breastfeeding Training & QI Project With funding from.
Best Start - Prenatal Education Program Prenatal Care.
FY14 Contract Training for Public Health Prenatal Program/Maternity Services Trina Miller Prenatal Program Coordinator Division of Child & Family Health.
Impact of the Affordable Care Act’s Coverage Mandate on State Newborn Screening Programs Presentation to Advisory Committee on Heritable Disorders in Newborns.
Georgia’s Newborn Surveillance & Tracking System (NSTS) Akilah Heggs, MA, CCC-A Susan Bertonaschi, M.S. Elisa Stamey, R.N. Georgia Division of Public Health.
History of the Other Work of the SACHDNC Alex R. Kemper, MD, MPH, MS September 22, 2011.
RecruitMAX: What is it? RecruitMAX is a web-based software system providing electronic tools for managing the lab’s employment processes.
Secretary’s Advisory Committee on Heritable Disorders of Newborns and Children September 22, 2011 Newborn Screening Translational Research Network (NBSTRN)
Lynn Douglas Mouden, DDS, MPH Chief Dental Officer Centers for Medicare & Medicaid Services Oral Health: Putting a Smile in Public Housing.
Update on Newborn Screening Use Case Advisory Committee on Heritable Diseases in Newborns and Children - Advisory Committee on Heritable Diseases in Newborns.
Bridge Communication. Best Start is distinct from other initiatives in that it: Best Start is a major redesign of services in terms of how children and.
Proposed Changes to Advisory Committee Processes Sara Copeland, MD Designated Federal Official Secretary’s Advisory Committee on Heritable Disorders in.
MCHB Activities to Integrate Newborn Screening & Other Child Health Information Systems Deborah Linzer Senior Public Health Analyst U.S. Department of.
Recommendations and a Plan for Preventing Preterm Birth Secretary’s Advisory Committee on Infant Mortality (SACIM) August 10, 2015.
Ethical and Regulatory Considerations in Research using Residual Specimens Jeffrey R. Botkin, M.D., M.P.H. Professor of Pediatrics and Medical Ethics Associate.
Partnering with School Nurses in the Medical Home Critical Issues in School Health May 20, 2010 Sandra Carbonari, M.D., FAAP Renae Vitale, LCSW Megin Coleman,
Overview of MCHB Programs Michael C. Lu, MD, MPH Associate Administrator Maternal and Child Health Bureau Health Resources and Services Administration.
United States Department of Health & Human Services Office of the Assistant Secretary for Preparedness and Response Cheryl Levine, Ph.D. At-Risk IndividualsTeam.
Evidence Review Group: Past to Present James M. Perrin, MD Professor of Pediatrics, Harvard Medical School MGH Center for Child and Adolescent Health Policy.
The NCC is funded by U22MC24100, awarded as a cooperative agreement between the Maternal and Child Health Bureau/Health Resources and Services Administration,
Newborn Screening for Severe Combined Immune Deficiency: Advocacy, Challenges, and Next Steps Marcia Boyle President and Founder Immune Deficiency Foundation.
WIC Pediatric Referral Form Tutorial
Copyright ©2011 Georgia Hospital Association Medicare Beneficiary Quality Improvement Project (MBQIP) ED Transfer Communication Abstraction Training July.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Medical Home Manuscript from the Subcommittee on Follow- up and Treatment Alex R. Kemper, MD, MPH, MS May 18, 2012.
(Slide 1 of 22) Response to the National Vaccine Advisory Committee Recommendations on the Immunization Safety Office Scientific Agenda Frank DeStefano,
Who makes up all these rules?? A discussion on Regulatory Agencies and how they relate to each other and our lab.
I have no relevant financial relationships with the manufacturers of any commercial products and/or provider of commercial services discussed in this CME.
Recommendation Methods Advisory Committee on Heritable Disorders and Genetic Diseases of Newborns and Children Ned Calonge, M.D., M.P.H.
Survey on Electronic Data Collection and Newborn Screening System Information Needs Assessment May 13, 2010 Advisory Committee on Heritable Disorders in.
U.S. Department of Commerce International Trade Administration Freight Policy and Movement Subcommittee Recommendation Improving U.S. Supply Chain Competitiveness.
1 Hospital Practices Influence Breastfeeding Rates: The Data Tell the Story Birth & Beyond California: Breastfeeding Training& QI Project.
Alyssa R. Vangeli Families USA Health Action Conference February 5, 2016 Using Medical Evidence to Design Health Insurance Benefits: Massachusetts No Copay.
Regional Genetics Service Collaboratives; setting the context for analyzing the impact Sara Copeland, MD Chief, Genetics Services Branch September 11,
CAPTA and Beyond: Referrals for developmental screenings for children involved with child welfare Introduction to Frequently Asked Questions Online Resource.
0 Ethics Lecture Research. ACADEMY OF OPHTHALMOLOGY Disclosures  The speaker has no financial interest in the subject matter of this.
Florida Cancer Plan Phil Roland, MD FACS FACOG Florida State Chair A Commission on Cancer.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Pulse Oximetry Screening for Critical Congenital Heart Disease (CCHD): The Wisconsin Experience Region IV Genetics Meeting September 11, 2012 Sharon Fleischfresser.
By: Alisa and Courtney Fourth Intro.  A respiratory therapist treats people with disorders affecting the cardiopulmonary system.  The RRT will diagnose.
A quality improvement program provided by the Ohio Chapter, American Academy of Pediatrics, Ohio Department of Health, CDC’s National Immunization Program.
IRB Presentation to the Pediatric Ethics Subcommittee of the FDA regarding “Gonadotropin Releasing Hormone (GnRH) Agonist Test in Disorders of Puberty”
Senate Appropriations Committee Approves Labor, HHS, and Education Bill That Is Less Than President’s Request June 10, 2016 | Ben Booker Sources: Senate.
The Future of the California Children’s Services (CCS) Program: Overview of CCS Laurie A. Soman Children’s Regional Integrated Service System (CRISS) Lucile.
FDA Drug Advisory Committee Pediatric Ethics Subcommittee Gonadotropin Releasing Hormone Agonist Test in Disorders of Puberty CHARGE TO COMMITTEE Norman.
About Newborn Screening  Newborn Screening Facts - A brief introduction to the most important information on newborn screening.
EMS for Children Day Celebrating EMS Week 2017 Wednesday May 24, 2017
Newborn Screening: Achieving Timeliness
The Early Hearing Detection & Intervention Program Overview
30 JANUARY 2019 PRIVATE HEALTH ESTABLISHMENTS
28 NOVEMBER 2018 PRIVATE HEALTH ESTABLISHMENTS
Presentation transcript:

Update on SACHDNC Administrative Processes Sara Copeland, MD Chief, Genetics Services Branch Designated Federal Officer Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children Department of Health and Human Services Health Resources and Services Administration Maternal and Child Health Bureau May 17, 2012

Contents Updates Organizational Representatives review Subcommittee procedures and processes Update to condition nominations

Updates 2013 Newborn Screening Saves Lives Act re-authorization –So far no action has been taken –Does not “sunset” so if funds are appropriated, programs can continue 2012 Annual Report –Reviewed and approved by AC –Sent to Secretary Sebelius

Organizational Representatives Nominations may be considered upon written requests to the DFO from individuals, organizations or the Committee. Requests should document the following: –perspective and expertise provided by the nominated representative –why this perspective and expertise would benefit the Committee – how the SACHDNC’s work affects and/or impacts the nominated representative’s organization and stakeholders –commitment of the nominated representative to provide expert input into the SACHDNC decision-making process, –source of funding for travel and per diem support, and –means of ensuring active dissemination to their representative constituencies about SACHDNC activities and recommendations. Nominations will be reviewed by the Chair and DFO prior to submission for Secretarial selection.

Organizational Representatives on SACHDNC SACHDNC Organization Representatives - Categories and Rotations Category# of RepsOrg NameNew Term Begins Federal AgenciesUp to 1Department of DefenseJan 2016 Public Health Constituencies - State and Local - includes hospitals and medical home Up to 2 Association of Public Health LaboratoriesJan 2013 Association of State and Territorial Health OfficialsJan 2016 Consumer/family organizations, advocacy groups Up to 2 Genetic AllianceJan 2014 March of DimesJan 2015 Primary Care - includes nursing Up to 3 American Academy of Family PhysiciansJan 2014 American Academy of PediatricsJan 2016 American College of Obstetricians and GynecologistsJan 2015 SubspecialtyUp to 2 Society for Inherited Metabolic DisordersJan 2015 American College of Medical GeneticsJan 2014 At Large RepsUp to 2 Child Neurology SocietyJan 2013 Vacant

Subcommittee Discussion For reports and projects sent forward for AC review

What Nature of Support is being requested? NATURE OF SUPPORTRECOMMENDATIONS AND/OR ACTIONS Official SACHDNC Support Products or Projects are FORWARDED TO S ECRETARY FOR CONSIDERATION / ACTION - in purview of SACHDNC and under authority of HHS Secretary SACHDNC Affirmation of Value to the Heritable Disorders and Newborn Screening Community Products or Projects are FORWARDED TO S ECRETARY FOR INFORMATION P URPOSES ONLY SACHDNC Acknowledgment Products or Projects are NOT FORWARDED TO THE S ECRETARY. A CKNOWLEDGMENT CITED ON SACHDNC WEBSITE No SupportN/A

Official SACHDNC Support with Actions: 1.What action(s) and/or recommendations is/are being requested? 2.Please list the pros and cons of each action and/or recommendation 3.What is the best mechanism for the Secretary to support these actions and/or recommendations?

Template for voting slide: Report title Nature of support requested If official support with actions –List of actions/recommendations –Pros and cons of each action/recommendation How can the Secretary best support these actions and/or recommendations for optimal outcomes?

Condition Nomination Forms Addition of a Pre-nomination requirement: –Comment: For a condition to be sent to the condition review group there are 3 core requirements: 1. A prospective population based pilot 2. Validation of the laboratory test 3. Widely available confirmatory testing with a sensitive and specific diagnostic test

PreNomination Preparation Comment: For a condition to be sent to the condition review group there are 3 core requirements: 1. A prospective population based pilot 2. Validation of the laboratory test 3. Widely available confirmatory testing with a sensitive and specific diagnostic test Population Based Pilot Location of prospective pilot Number of infants screened Number of screen positive results Number of infants confirmed with diagnosis Laboratory Test Validation (as applicable) Analytical SensitivityAnalytical Specificity Reportable Range of Test results Reference Range Confirmatory testing Type of test (blood, radiology, urine, tissue sample, biophysical test) Is test FDA and/or CLIA certified? (Y/N) Offered routinely at >2 CLIA certified labs in the US and where?

Contact Information Sara Copeland, MD Designated Federal Officer